Literature DB >> 20307794

The first decade of the National Drug Abuse Treatment Clinical Trials Network: bridging the gap between research and practice to improve drug abuse treatment.

Betty Tai1, Michele M Straus, David Liu, Steven Sparenborg, Ron Jackson, Dennis McCarty.   

Abstract

The National Institute on Drug Abuse established the National Drug Abuse Treatment Clinical Trials Network (CTN) in 1999 to improve the quality of addiction treatment using science as the vehicle. The network brings providers from community-based drug abuse treatment programs and scientists from university-based research centers together in an alliance that fosters bidirectional communication and collaboration. Collaboration enhanced the relevance of research to practice and facilitated the development and implementation of evidence-based treatments in community practice settings. The CTN's 20 completed trials tested pharmacological, behavioral, and integrated treatment interventions for adolescents and adults; more than 11,000 individuals participated in the trials. This article reviews the rationale for the CTN, describes the translation of its guiding principles into research endeavors, and anticipates the future evolution of clinical research within the Network.

Entities:  

Mesh:

Year:  2010        PMID: 20307794      PMCID: PMC2994254          DOI: 10.1016/j.jsat.2010.01.011

Source DB:  PubMed          Journal:  J Subst Abuse Treat        ISSN: 0740-5472


  50 in total

Review 1.  A comprehensive guide to the application of contingency management procedures in clinical settings.

Authors:  N M Petry
Journal:  Drug Alcohol Depend       Date:  2000-02-01       Impact factor: 4.492

Review 2.  Community-based intervention research: coping with the "noise" of real life in study design.

Authors:  Ann A Hohmann; M Katherine Shear
Journal:  Am J Psychiatry       Date:  2002-02       Impact factor: 18.112

3.  Practice-based research--"Blue Highways" on the NIH roadmap.

Authors:  John M Westfall; James Mold; Lyle Fagnan
Journal:  JAMA       Date:  2007-01-24       Impact factor: 56.272

4.  Using buprenorphine to facilitate entry into residential therapeutic community rehabilitation.

Authors:  Eric D Collins; Terry Horton; Katherine Reinke; Leslie Amass; Edward V Nunes
Journal:  J Subst Abuse Treat       Date:  2006-11-21

5.  Prize-based contingency management does not increase gambling.

Authors:  Nancy M Petry; Ken B Kolodner; Rui Li; Jessica M Peirce; John M Roll; Maxine L Stitzer; John A Hamilton
Journal:  Drug Alcohol Depend       Date:  2006-01-10       Impact factor: 4.492

6.  Effects of adding behavioral treatment to opioid detoxification with buprenorphine.

Authors:  W K Bickel; L Amass; S T Higgins; G J Badger; R A Esch
Journal:  J Consult Clin Psychol       Date:  1997-10

7.  Buprenorphine tapering schedule and illicit opioid use.

Authors:  Walter Ling; Maureen Hillhouse; Catherine Domier; Geetha Doraimani; Jeremy Hunter; Christie Thomas; Jessica Jenkins; Albert Hasson; Jeffrey Annon; Andrew Saxon; Jeffrey Selzer; Joshua Boverman; Richard Bilangi
Journal:  Addiction       Date:  2009-02       Impact factor: 6.526

8.  Smoking cessation treatment in community-based substance abuse rehabilitation programs.

Authors:  Malcolm S Reid; Bryan Fallon; Susan Sonne; Frank Flammino; Edward V Nunes; Huiping Jiang; Eva Kourniotis; Jennifer Lima; Ron Brady; Cynthia Burgess; Cynthia Arfken; Eric Pihlgren; Louis Giordano; Aron Starosta; James Robinson; John Rotrosen
Journal:  J Subst Abuse Treat       Date:  2007-10-24

9.  Practical behavioral trials to advance evidence-based behavioral medicine.

Authors:  Russell E Glasgow; Karina W Davidson; Patricia L Dobkin; Judith Ockene; Bonnie Spring
Journal:  Ann Behav Med       Date:  2006-02

Review 10.  Psychosocial interventions for cocaine and psychostimulant amphetamines related disorders.

Authors:  W P Knapp; B G O Soares; M Farrel; M S Lima
Journal:  Cochrane Database Syst Rev       Date:  2007-07-18
View more
  42 in total

1.  Rationale and methods for site selection for a trial using a novel intervention to treat stimulant abuse.

Authors:  Diane Warden; Madhukar H Trivedi; Tracy L Greer; Edward Nunes; Bruce D Grannemann; Viviana E Horigian; Eugene Somoza; Kolette Ring; Tiffany Kyle; José Szapocznik
Journal:  Contemp Clin Trials       Date:  2011-09-17       Impact factor: 2.226

2.  Item banks for substance use from the Patient-Reported Outcomes Measurement Information System (PROMIS(®)): Severity of use and positive appeal of use.

Authors:  Paul A Pilkonis; Lan Yu; Nathan E Dodds; Kelly L Johnston; Suzanne M Lawrence; Thomas F Hilton; Dennis C Daley; Ashwin A Patkar; Dennis McCarty
Journal:  Drug Alcohol Depend       Date:  2015-09-21       Impact factor: 4.492

3.  Improving treatment for opioid dependence: a perspective from the Ohio Valley node of the NIDA Clinical Trials Network.

Authors:  Erin L Winstanley; Greg S Brigham; Dean Babcock; Theresa Winhusen
Journal:  Prog Community Health Partnersh       Date:  2014

4.  Direct-to-Consumer Marketing: A Complementary Approach to Traditional Dissemination and implementation Efforts for Mental Health and Substance Abuse Interventions.

Authors:  Sara J Becker
Journal:  Clin Psychol (New York)       Date:  2015-03-01

5.  The substance abuse counseling workforce: education, preparation, and certification.

Authors:  Traci Rieckmann; Christiane Farentinos; Carrie J Tillotson; Jonathan Kocarnik; Dennis McCarty
Journal:  Subst Abus       Date:  2011-10       Impact factor: 3.716

6.  Technology transfer for the implementation of a clinical trials network on drug abuse and mental health treatment in Mexico.

Authors:  Viviana E Horigian; Rodrigo A Marín-Navarrete; Rosa E Verdeja; Elizabeth Alonso; María A Perez; José Fernández-Mondragón; Carlos Berlanga; María Elena Medina-Mora; José Szapocznik
Journal:  Rev Panam Salud Publica       Date:  2015-09

7.  Organizational Predictors and Use of Evidence-Based Practices in Adolescent Substance Abuse Treatment.

Authors:  Maria Paino; Lydia Aletraris; Paul M Roman
Journal:  Subst Abus       Date:  2014-09-25       Impact factor: 3.716

8.  Comparison of opiate-primary treatment seekers with and without alcohol use disorder.

Authors:  Bryan Hartzler; Dennis M Donovan; Zhen Huang
Journal:  J Subst Abuse Treat       Date:  2010-07-03

Review 9.  Implementing a continuum of evidence-based psychosocial interventions for people with severe mental illness: part 1-review of major initiatives and implementation strategies.

Authors:  Matthew Menear; Catherine Briand
Journal:  Can J Psychiatry       Date:  2014-04       Impact factor: 4.356

10.  Mortality Rates Among Substance Use Disorder Participants in Clinical Trials: Pooled Analysis of Twenty-Two Clinical Trials Within the National Drug Abuse Treatment Clinical Trials Network.

Authors:  Robert Lindblad; Lian Hu; Neal Oden; Paul Wakim; Carmen Rosa; Paul VanVeldhuisen
Journal:  J Subst Abuse Treat       Date:  2016-08-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.